Vivos Therapeutics's total assets for Q1 2024 were $11.80M, an increase of 14.41% from the previous quarter. VVOS total liabilities were $11.20M for the fiscal quarter, a 8.74% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.